The Autonomy study: the ability to make decisions and have a say in the direction of our lives

For older people, getting cancer is more common. If someone is already quite old or has other health problems, they might not expect to live a very long time, even without cancer. When it comes to treating cancer in these situations, doctors and patients face tough decisions. Some powerful cancer treatments can have unpleasant side effects that make day-to-day life difficult. These treatments might prolong life, but sometimes not by much, especially if someone is already frail or has multiple health conditions. On the other hand, gentler treatments might not be as good at getting rid of the cancer, but they could mean fewer side effects, allowing people to feel better and enjoy a good quality of life.

This study is about helping patients and doctors work together to make these important choices. It's called "shared decision-making." The goal is to make sure the treatment plan truly reflects what the patient wants for their life. For example, some people might prefer treatment that allows them to stay active and independent for as long as possible, even if it means accepting a slightly shorter lifespan. Others might prioritize getting rid of the cancer at almost any cost. At the moment, doctors don't always have a clear way to understand these personal preferences from their patients.

That's where the Autonomy study comes in. Researchers are developing a new "tool" – like a guiding questionnaire or discussion aid – to help doctors talk with older cancer patients about what matters most to them. This tool will help doctors understand whether a patient values a longer life or a better quality of life more. While similar tools exist for cancers that can't be cured, this study focuses on patients whose cancer could be cured, but whose overall health limits their life expectancy. The hope is that this new tool will lead to better, more personalised treatment decisions for older patients in the future.